Personal information

No personal information available

Activities

Collapse all

Works (9)

Data from Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

2024-03-04 | Preprint
DOI: 10.1158/1535-7163.c.7104451.v1
Contributors: Kanae Imai; Yuki Takeuchi; Seitaro Terakura; Shingo Okuno; Yoshitaka Adachi; Masahide Osaki; Koji Umemura; Ryo Hanajiri; Kazuyuki Shimada; Makoto Murata et al.
Source: check_circle
Crossref

Data from Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

2024-03-04 | Preprint
DOI: 10.1158/1535-7163.c.7104451
Contributors: Kanae Imai; Yuki Takeuchi; Seitaro Terakura; Shingo Okuno; Yoshitaka Adachi; Masahide Osaki; Koji Umemura; Ryo Hanajiri; Kazuyuki Shimada; Makoto Murata et al.
Source: check_circle
Crossref

Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

Molecular Cancer Therapeutics
2024-03-04 | Journal article
DOI: 10.1158/1535-7163.MCT-23-0408
Contributors: Kanae Imai; Yuki Takeuchi; Seitaro Terakura; Shingo Okuno; Yoshitaka Adachi; Masahide Osaki; Koji Umemura; Ryo Hanajiri; Kazuyuki Shimada; Makoto Murata et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

2024-03-04 | Preprint
DOI: 10.1158/1535-7163.25337992
Contributors: Kanae Imai; Yuki Takeuchi; Seitaro Terakura; Shingo Okuno; Yoshitaka Adachi; Masahide Osaki; Koji Umemura; Ryo Hanajiri; Kazuyuki Shimada; Makoto Murata et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

2024-03-04 | Preprint
DOI: 10.1158/1535-7163.25337992.v1
Contributors: Kanae Imai; Yuki Takeuchi; Seitaro Terakura; Shingo Okuno; Yoshitaka Adachi; Masahide Osaki; Koji Umemura; Ryo Hanajiri; Kazuyuki Shimada; Makoto Murata et al.
Source: check_circle
Crossref

Supplementary FIgure S2 from Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

2024-03-04 | Preprint
DOI: 10.1158/1535-7163.25337995
Contributors: Kanae Imai; Yuki Takeuchi; Seitaro Terakura; Shingo Okuno; Yoshitaka Adachi; Masahide Osaki; Koji Umemura; Ryo Hanajiri; Kazuyuki Shimada; Makoto Murata et al.
Source: check_circle
Crossref

Supplementary FIgure S2 from Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

2024-03-04 | Preprint
DOI: 10.1158/1535-7163.25337995.v1
Contributors: Kanae Imai; Yuki Takeuchi; Seitaro Terakura; Shingo Okuno; Yoshitaka Adachi; Masahide Osaki; Koji Umemura; Ryo Hanajiri; Kazuyuki Shimada; Makoto Murata et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

2024-03-04 | Preprint
DOI: 10.1158/1535-7163.25337989.v1
Contributors: Kanae Imai; Yuki Takeuchi; Seitaro Terakura; Shingo Okuno; Yoshitaka Adachi; Masahide Osaki; Koji Umemura; Ryo Hanajiri; Kazuyuki Shimada; Makoto Murata et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

2024-03-04 | Preprint
DOI: 10.1158/1535-7163.25337989
Contributors: Kanae Imai; Yuki Takeuchi; Seitaro Terakura; Shingo Okuno; Yoshitaka Adachi; Masahide Osaki; Koji Umemura; Ryo Hanajiri; Kazuyuki Shimada; Makoto Murata et al.
Source: check_circle
Crossref
How many people are using ORCID?